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A paper presented at a conference in Prague led to a flurry of media 
interest and worries. Nigel Williams reports.
New embryo research sparks fearsThe news that thousands of 
women at risk of giving birth to 
sick children could benefit from a 
revolutionary technique to ensure 
that their babies are free from 
genetic disorders hit the headlines 
in Britain last month where the 
technique was developed. Five 
women in the country are pregnant 
after having their embryos tested 
using the technique, which 
can screen out the genes for 
common disorders such as cystic 
fibrosis and Duchenne muscular 
dystrophy.
The gene for cystic fibrosis 
is carried by up to one in 25 
individuals in some populations 
and Duchenne muscular dystrophy 
affects one in every 3,500 male 
births in Britain. These are just two 
of more than 1,000 single-gene 
disorders that could be identified 
by the technique.
Television news bulletins led 
with the story throughout the 
day following the announcement 
by researchers at a meeting in 
the Czech Republic. And they, 
and most of the broadsheet 
newspapers, went into some 
detail on the novelty of the work 
and its potential benefits for 
families. But for others the spectre 
of ‘designer babies’ was thought 
to be the main issue to grab 
their readers. 
For about ten years it has been 
possible to test in vitro fertilisation 
(IVF) embryos for certain genetic 
diseases in order to implant 
only healthy embryos. But this 
complicated method of pre-
implantation genetic diagnosis 
(PGD) has limitations, according 
to experts.
The new procedure is more 
accurate, more powerful and 
marks a radical development in 
the technology of testing embryos, 
said Peter Braude, professor of 
obstetrics and gynaecology at 
King’s College London. “We really 
think this is a big, big change in 
terms of what we usually do. This changes everything, it really does,” 
he said.
PGD involves taking a single 
cell from an IVF embryo and 
testing the minute quantities of 
DNA it contains for the presence 
of a known mutation for genetic 
disorders such as cystic fibrosis.
The new procedure, called pre-
implantation genetic haplotyping 
(PGH), takes a single cell and 
multiplies its entire genetic 
complement a million-fold before 
testing whether the embryo has 
inherited the defective part of 
a chromosome from its father 
or mother.
The media reports highlighted 
the significance of not needing to 
know the exact genetic details. 
“It just opens doors to all sorts of disorders,” Braude said. 
“It improves dramatically the 
diagnostic success rate because 
you can make the diagnosis 
more reliably and you have more 
embryos at the end of it. It’s more 
accurate, it has higher reliability, 
it’s going to be available for a 
whole range of disorders,” said 
Braude, who announced the work 
at the European Society of Human 
Reproduction and Embryology’s 
meeting in Prague last month.
But for the Daily Mail the new 
work rang alarm bells about 
designer babies and techniques 
that lead to the selection of 
embryos of a particular sex. 
It featured a claim that one 
London clinic had applied to use 
IVF selection to eliminate male 
embryos from couples with a family 
history of autism, which occurs 
predominantly in male offspring.Concerns: Fears were raised by some media about new embryo techniques hailed by 
most as offering new advantages. 
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Coral reefs and the diversity of 
ocean life they attract and shelter 
are major tourist attractions in 
many areas around the world 
from the Caribbean to the South 
Pacific. Now it appears that human 
activities, including tourism, are 
putting their very existence at risk. 
A first warning sign was the 
bleaching of corals, observed 
in many locations since the late 
1980s. Apparently, environmental 
stress triggers the colonial animal 
to lose the symbiotic algae that 
provide corals not only with the 
characteristic colour but also with 
nutrition. Therefore, prolonged 
bleaching can kill the coral entirely.
While there is little information  
on how and why the stressed 
coral parts company with its 
symbiont, several environmental 
risk factors have been identified, 
including water temperature.
Corals typically tolerate a 
temperature range from 25 to 
29ºC. Bleaching will occur if 
the temperature remains above 
that range for too long. In the 
laboratory, the process has been 
reproduced by exposure to 32ºC.
John Rollino, a Senior Ecologist at 
Earth Tech Inc. has been conducting 
the Bahamian Reef Survey since 
1992, supported by volunteer 
helpers provided by the Earthwatch 
Institute. Over that period, he and 
his coworkers have witnessed a 
drastic decline in coral reefs. “In 
2005, huge portions of the reefs in 
the eastern Caribbean underwent 
drastic decline due to coral 
mortality from above average water 
temperatures,” Rollino says. “Some 
of the individual coral colonies that 
perished last year were alive over a 
hundred years ago.”
As a result, two of the coral 
species concerned, namely 
staghorn (Acropora cervicornis) and 
elkhorn (Acropora palmata) are now 
listed as ‘threatened’ under the US 
Endangered Species Act (ESA), the 
first coral species to be awarded 
A new analysis of corals finds key 
species threatened by changing 
environments. Michael Gross 
reports.
Key to coral 
warming stress
Structural attack: The staghorn coral appears particularly vulnerable to changing sea 
temperatures and reef conditions. (Photo: Oxford Scientific Films.)But one of the advantages of 
the new technique, as much of the 
media pointed out, is the ability 
to discriminate between afflicted 
males and, indeed, carrier and 
normal females.
PGH can identify the 50 per 
cent of male embryos that will 
be unaffected, said Allison 
Lashwood, a consultant nurse at 
Guy’s and St Thomas’ Hospital 
in London. “We can tell the 
difference between the affected 
and the unaffected males and 
that, for some couples, will make 
a difference between whether 
they get an embryo transfer 
or not,” Lashwood said. “By 
using this technology we are 
hopefully increasing the number 
of embryos,” she said.
Pam Renwick, the geneticist 
at Guy’s Hospital who has 
pioneered the test’s development, 
said that the technique can be 
applied to any genetic disease 
where the mutation has been 
located on a region of a particular 
chromosome. “It’s a universal 
test for all families and it has the 
added advantage that we can now 
select for unaffected males, which 
increases the number of embryos 
for transfer into the womb,” 
Renwick said.
The PGH test can also 
distinguish between female 
embryos that are healthy carriers 
of a defective gene from those 
that are completely free, non-
carriers. This raises the ethical 
issue of whether to offer couples 
the opportunity to discard female 
embryos that are healthy carriers 
in favour of healthy non-carriers. 
Braude said: “If you are looking 
at  the eugenic implications 
of saying that we are trying to 
eliminate a disease from a family, 
that’s a completely different story 
from what we are trying to do,” 
he said.
“This is nothing to do with 
screening. This is to do with 
families at significant risk who can 
choose this technique over pre-
natal diagnosis and termination of 
pregnancy. The easy way is you 
get pregnant, test the pregnancy 
and abort if it is no good. Some 
people have done that repeatedly 
and don’t want to do it again, or 
they have religious objections to 
termination,” he said.
